LECT2 and metabolic dysfunction-associated steatotic liver disease: All in all, LECT2 may mediate the progression of NAFLD by promoting liver lipid accumulation and inflammation as well as IR through STAT-1 signaling pathway, which might provide new insights into the diagnosis and treatment of NAFLD.